Organismal Biologists Get Organized

Organismal-level biologists from the more than 70 professional societies involved in the American Institute of Biological Sciences (AIBS) have recently come together to set common goals in such areas as policy and education. The process started last November when 57 leaders from the member societies gathered for the inaugural Presidents' Summit, the first event of its kind in AIBS's 53-year history. After an extended weekend of prioritizing and synthesizing ideas, the leaders identified 11 initi

Written byKaren Young Kreeger
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Organismal-level biologists from the more than 70 professional societies involved in the American Institute of Biological Sciences (AIBS) have recently come together to set common goals in such areas as policy and education. The process started last November when 57 leaders from the member societies gathered for the inaugural Presidents' Summit, the first event of its kind in AIBS's 53-year history. After an extended weekend of prioritizing and synthesizing ideas, the leaders identified 11 initiatives for consideration. These included expanding the group's collective voice in federal public-policy decisions, launching a public-education program on evolution, and evaluating and proposing models for undergraduate biology curricula.

Overarching groups that represent other areas of science, such as biomedical researchers in the Federation of American Societies for Experimental Biology (FASEB), chemists in the American Chemical Society, or physical scientists in the American Institute of Physics, have been organizing joint projects on behalf of their constituent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies